Rosemary Gale

10PUBLICATIONS
80CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMedical mycologyMedical virologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|May 01, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.

Jad Othman, Nicola Potter, Adam Ivey

|Jan 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AML.

Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer

|Dec 06, 2021
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia.

David C Linch, Robert K Hills, Alan K Burnett

|Feb 01, 2020
The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia.

David C Linch, Robert K Hills, Alan K Burnett

|Oct 10, 2019
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.

David C Linch, Robert K Hills, Alan K Burnett

Pageof 2

Frequent Collaborators

3 joint publications

Robert K Hills

2 joint publications

David C Linch

1 joint publications

Nigel Russell

1 joint publications

Wei-Yu Lin